Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Explore the best cash back rewards credit cards and optimize your spending to get rewarded effectively. Discover your top picks today!
23,783 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
The March 2026 PCE data show the fed's favored inflation gauge staying elevated, signaling limited relief for househo...
Base, the Coinbase-backed Ethereum Layer 2, is shifting from optimistic rollups to a zero-knowledge-based finality sy...
Bitcoin gains momentum, rising about 6% over the past week and briefly topping $83,000 before pulling back. Traders a...
BlackRock’s entry into XRP exposure signals a broader institutional push, with XRP hovering around $1.41 as regulator...
In 2026, the Social Security earnings test can quietly trim benefits for those who work before full retirement age. T...
Soccer has overtaken baseball in U.S. popularity, a shift that could reshape family entertainment budgets and the val...
Tron’s TRX surged in 2026, yet fresh on-chain data points to a potential correction risk as price outpaces network ac...
Accredited investors can now access a portfolio of 25,000+ multifamily units via Lightstone's private-market platform...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
When social security disability converts to retirement at full retirement age, beneficiaries keep their current month...
Coinbase and MicroStrategy’s Strategy stock both fell as investors trimmed exposure to digital asset names amid profi...